Logo

NIDDK Renews License to GeneGo's MetaCore Software

Aug 16, 2006
NEW YORK (GenomeWeb News) — GeneGo said today that that the National Institute of Diabetes and Digestive and Kidney Diseases has renewed its MetaCore license to continue researching insulin-resistant diabetes in human and animal models.
 
Tatiana Nikolskaya, chief scientific officer and president of GeneGo, said the collaboration "is a very important part of our development program in this field."
 
Financial details were not disclosed.

Filed under

Informatics
Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.